IC-MedTech is a pharmaceutical company specializing in the development of intellectual property for small molecules as primary and pan-adjuvant therapies for cancer, inflammatory, and genetic diseases. Their focus is on providing patients with less toxic and cost-effective options. They also specialize in drug development and new tablet dose with analytical methods. IC-MedTech aims to develop safer and more affordable treatments for infectious diseases and cancer.